Users' guides to the medical literature: XX. Integrating research evidence with the care of the individual patient

JAMA

Volumn 283, Issue 21, 2000, Pages 2829-2836

  McAlister, Finlay A ^d   Straus, Sharon E ^b   Guyatt, Gordon H ^a,c   Haynes, R Brian ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEATH; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL RESEARCH; PATIENT CARE; PATIENT COMPLIANCE; PATIENT RIGHT; PRIORITY JOURNAL; PROBABILITY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STATISTICAL ANALYSIS; STROKE;

EID: 0034616749     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.21.2829     Document Type: Review

References (76)

1. Sauve JS, Laupacis A, Ostbye T, Feagan B, Sackett DL. Does this patient have a clinically important carotid bruit? JAMA. 1993;270:2843-2845.
2. Eliasziw M, Rankin RN, Fox AJ, Haynes RB, Barnett HJ. Accuracy and prognostic consequences of ultrasonography in identifying severe carotid artery stenosis. Stroke. 1995;26:1747-1752.
3. Eliasziw M, Streifler JY, Fox AJ, et al. Significance of plaque ulceration in symptomatic patients with high-grade carotid stenosis. Stroke. 1994;25:304-308.
4. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med. 1998; 339:1415-1425.
5. Yusuf S, Held P, Teo KK. Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria. Stat. Med. 1990;9: 73-86.
6. Guyatt GH, Sackett DL, Cook DJ, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature, II: how to use an article about therapy or prevention, A: are the results of the study valid? JAMA. 1993;270:2598-2601.
7. Guyatt GH, Sackett DL, Cook DJ, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature, II: how to use an article about therapy or prevention, B: what were the results and will they help me in caring for my patients? JAMA. 1994;271:59-63.
8. Dans AL, Dans LF, Guyatt GH, Richardson S, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature, XIV: how to decide on the applicability of clinical trial results to your patient. JAMA. 1998;279:545-549.
9. Guyatt GH, Sinclair J, Cook DJ, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature, XVI: how to use a treatment recommendation. JAMA. 1999;281:1836-1843.
10. Glasziou P, Guyatt GH, Dans AL, Dans LF. Straus S, Sackett DL. Applying the results of trials and systematic reviews to individual patients [editorial]. ACP J Club. 1998;129:A15-A16.
11. Garg R, Yusuf S, for the Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 1995;273:1450-1456.
12. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998;339:489-497.
13. McAlister FA, Taylor L, Teo KK et al. The treatment and prevention of coronary heart disease in Canada: do older patients receive efficacious therapies? J Am Geriatr Soc. 1999;47:811-818.
14. Chassin MR. Appropriate use of carotid endarterectomy. N Engl J Med. 1998;339:1468-1471.
15. Tu JV, Hannan EL, Anderson GM, et al. The fall and rise of carotid endarterectomy in the United States and Canada. N Engl J Med. 1998;339:1441-1447.
16. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med. 1988;318:1728-1733.
17. Sackett DL, Haynes RB. Summarising the effects of therapy: a new table and some more terms [editorial]. ACP J Club. 1997;127:A15-A16.
18. McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. Ann Intern Med. 1997;126:712-720.
19. Rothwell PM, Slattery J, Warlow CP. A systematic review of the risks of stroke and death due to end-arterectomy for symptomatic carotid stenosis. Stroke. 1996;27:260-265.
20. Sackett DL, Deeks JJ, Altman DG. Down with odds ratios! Evidence-Based Med. 1996;1:164-166.
21. Zhang J, Yu KF. What's the relative risk? JAMA. 1998;280:1690-1691.
22. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-Based Medicine: How to Practice and Teach EBM. London, England: Churchill-Livingstone; 2000.
23. Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA. 1991;266:93-98.
24. Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med. 1992;116: 78-84.
25. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154: 1449-1457.
26. Scandinavian Simvastatin Survival Study Group. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet. 1995;345:1274-1275.
27. ACE Inibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100000 patients in randomized trials. Circulation. 1998;97:2202-2212.
28. Fibrinolytic Therapy Trialists' Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311-322.
29. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344:563-570.
30. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease, 2: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827-838.
31. Davey Smith G, Egger M. Who benefits from medical interventions? BMJ. 1994;308:72-74.
32. Sharp SJ, Thompson SG, Altman DG. The relation between treatment benefit and underlying risk in meta-analysis. BMJ. 1996;313:735-738.
33. Rothwell PM. Can overall results of clinical trials be applied to all patients? Lancet. 1995;345:1616-1619.
34. Schmid CH, Lau J, McIntosh MW, Cappelleri JC. An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials. Stat Med. 1998;17:1923-1942.
35. Ioannidis JP, Lau J. Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm. Am J Epidemiol. 1998; 148:1117-1126.
36. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325: 445-453.
37. The Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995; 273:1421-1428.
38. Stewart LA, Clarke MJ. Practical methodology of meta-analyses (overviews) using updated individual patient data. Stat Med. 1995;14:2057-2079.
39. Laupacis A, Sekar N, Stiell IG. Clinical prediction rules: a review and suggested modifications of methodological standards, JAMA. 1997;277:488-494.
40. Glasziou PP, Irwig LM. An evidence-based approach to individualising treatment. BMJ. 1995;311: 1356-1359.
41. The European Carotid Surgery Trialists' Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379-1387.
42. Rothwell PM, Warlow CP. Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study Lancet. 1999;353:2105-2110.
43. Laupacis A, Wells G, Richardson WS, Tugwell P, for the Evidence-Based Medicine Working Group. User's guides to the medical literature, V: how to use an article about prognosis. JAMA. 1994;272:234-237.
44. Elneihoum AM, Goransson M, Falke P, Janzon L. Three-year survival and recurrence after stroke in Malmo, Sweden: an analysis of stroke registry data. Stroke. 1998;29:2114-2117.
45. Rothwell PM, Slattery J, Warlow CP. Clinical and angiographic predictors of stroke and death from carotid endarterectomy: systematic review. BMJ. 1997; 315:1571-1577.
46. Chatellier G, Zapletal E, Lemaitre D, Menard J, Degoulet P. The number needed to treat: a clinically useful nomogram in its proper context. BMJ. 1996;312: 426-429.
47. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995;310:452-454.
48. Grover SA, Lowensteyn I, Esrey KL, et al. Do doctors accurately assess coronary risk in their patients? preliminary results of the coronary health assessment study. BMJ. 1995;310:975-978.
49. Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature, IX: a method for grading health care recommendations. JAMA. 1995;274:1800-1804.
50. Solomon NA, Glick HA, Russo CJ, Lee J, Schulman KA. Patient preferences for stroke outcomes. Stroke. 1994;25:1721-1725.
51. Nease RF, Kneeland T, O'Connor GT, et al. Variation in patient utilities for outcome of the management of chronic stable angina: implications for clinical practice guidelines. JAMA. 1995;273:1185-1190.
52. Samsa GP, Matchar DB, Goldstein L, et al. Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke. Am Heart J. 1998;136:703-713.
53. Sculpher M. The cost-effectiveness of preference-based treatment allocation: the case of hysterectomy versus endometrial resection in the treatment of menorrhagia. Health Econ. 1998;7:129-142.
54. Llewellyn-Thomas HA. Investigating patients' preferences for different treatment options. Can J Nurs Res. 1997;29:45-64.
55. Richardson WS, Detsky AS, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature, VII: how to use a clinical decision analysis, B: what are the results and will they help me in caring for my patients? JAMA. 1995;273:1610-1613.
56. Szabo E, Moody H, Hamilton T, Ang C, Kovithavongs C, Kjellstrand C. Choice of treatment improves quality of life: a study of patients undergoing dialysis. Arch Intern Med. 1997;157:1352-1356.
57. Greenfield S, Kaplan SH, Ware JE Jr, Yano EM, Frank HJ. Patients' participation in medical care: effects on blood sugar control and quality of life in diabetes. J Gen Intern Med. 1988;3:448-457.
58. Kaplan SH, Greenfield S, Ware JE Jr. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care. 1989;27(suppl 3):S110-S127.
59. Schulman BA. Active patient orientation and outcomes in hypertension treatment: application of a socio-organizational perspective. Med Care. 1979;17:267-280.
60. Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ. 1995; 152:1423-1433.
61. Vickery DM, Golaszewski TJ, Wright EC, Kalmer H. The effect of self-care interventions on the use of medical service within a Medicare population. Med Care. 1988;26:580-588.
62. Gage BF, Cardinalli AB, Owens DK. Cost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fibrillation. Stroke. 1998;29:1083-1091.
63. Strull WM, Lo B, Charles G. Do patients want to participate in medical decision making? JAMA. 1984; 252:2990-2994.
64. Degner LF, Kristjanson LJ, Bowman D, et al. Information needs and decisional preferences in women with breast cancer. JAMA. 1997;277:1485-1492.
65. Stiggelbout A, Kiebert GM. A role for the sick role. CMAJ. 1997;157:383-389.
66. Rothenbacher D, Lutz MP, Porzsolt F. Treatment decisions in palliative cancer care: patients' preferences for involvement and doctors' knowledge about it. Eur J Cancer. 1997;33:1184-1189.
67. Mazur DJ, Hickam DH. Patients' preferences for risk disclosure and role in decision making for invasive medical procedures. J Gen Intern Med. 1997;12: 114-117.
68. Margalith I, Shapiro A. Anxiety and patient participation in clinical decision-making: the case of patients with ureteral calculi. Soc Sci Med. 1997;45:419-427.
69. Torrance GW. Measurement of health state utilities for economic appraisal: a review. J Health Econ. 1986;5:1-30.
70. Lilford RJ, Pauker SG, Braunholtz A, Chard J. Decision analysis and the implementation of research findings. BMJ. 1998;317:405-409.
71. Riegelman R, Schroth WS. Adjusting the number needed to treat: incorporating adjustments for the utility and timing of benefits and harms. Med Decis Making. 1993;13:247-252.
72. Llewellyn-Thomas HA, McGreal MJ, Thiel EC, et al. Patients' willingness to enter clinical trials: measuring the association with perceived benefit and decision making preference. Soc Sci Med. 1991;32:35-42.
73. Levine MN, Gafni A, Markham B, MacFarlane D. A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med. 1992;117:53-58.
74. O'Connor AM. Consumer/patient decision support in the new millennium: where should our research take us? Can J Nurs Res. 1997;29:7-12.
75. O'Connor AM, Rostom A, Fiset V, et al. Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ. 1999;319:731-734.
76. Bain DJ, Fergie N, Quin RO, Greene M. Role of arteriography in the selection of patients for carotid endarterectomy. Br J Surg. 1998;85:768-770.